GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimi Health Corp (STU:8BN) » Definitions » Intrinsic Value: Projected FCF

Optimi Health (STU:8BN) Intrinsic Value: Projected FCF : €0.00 (As of Mar. 04, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Optimi Health Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-03-04), Optimi Health's Intrinsic Value: Projected FCF is €0.00. The stock price of Optimi Health is €0.112. Therefore, Optimi Health's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Optimi Health's Intrinsic Value: Projected FCF or its related term are showing as below:

STU:8BN's Price-to-Projected-FCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.59
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Optimi Health Intrinsic Value: Projected FCF Historical Data

The historical data trend for Optimi Health's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimi Health Intrinsic Value: Projected FCF Chart

Optimi Health Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
Intrinsic Value: Projected FCF
- - - - -

Optimi Health Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Optimi Health's Intrinsic Value: Projected FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Optimi Health's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optimi Health's Price-to-Projected-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Optimi Health's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Optimi Health's Price-to-Projected-FCF falls into.



Optimi Health Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Optimi Health  (STU:8BN) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Optimi Health's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.112/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optimi Health Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Optimi Health's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Optimi Health Business Description

Traded in Other Exchanges
Address
21 Water Street, Suite 600, Vancouver, BC, CAN, V6B 1A1
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.

Optimi Health Headlines

No Headlines